TechWeb

PRA International Rolls out Client Access to Oracle(R) RDC for Early Phase Studies

Jan 15, 2010 (09:01 AM EST)
URL: http://www.techweb.com/show-press-release/X787095/pra-international-rolls-out-client-access-to-oracle-r-rdc-for-early-phase-studies.html

RALEIGH, N.C., Jan. 15 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces that it will begin providing a client-facing portal into Oracle(R) Remote Data Capture (RDC) for its early phase studies in its Clinical Pharmacology Units in The Netherlands and the United States. Through the portal, clients working with PRA will have direct access to review RDC data. The portal provides sponsors with the ability to review all entered data, to move between subjects and pages, to see the multiple page views within the system and to compare separate pages in a side-by-side fashion.

Perhaps the most important benefit from this application is improved efficiency in study monitoring. A study monitor can monitor remotely either as a replacement for some site visits or to review data ahead of time in preparation for a site visit. This results in higher quality data and lower study costs through the reduction of monitoring time and queries. Other benefits from this system include the potential for increased client visibility into any potential safety concerns (via live data review) and enhanced communication regarding potential data issues between the client and PRA.

PRA's Early Development Services (EDS) group provides comprehensive services for phase I and phase IIa studies in healthy volunteers or special patient populations. Our expertise is primarily with more complex types of studies in which safety and intelligent design are critical factors.

PRA International conducts clinical trials in more than 75 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in oncology, neurosciences, respiratory/allergy, cardiovascular and infectious diseases. PRA has supported over 2,100 clinical trials through its 36+ global offices.

PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating ESONL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE ESONL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit Endpoints@PRAintl.com, email or call our Global Headquarters at +1 (919) 786-8200.

CONTACT: Roger Boutin, Director of Marketing of PRA International, Inc.,+1-434-951-3924

Web site: http://www.prainternational.com/